Summary
Theophylline total body clearance was calculated in 59 adult patients requiring intravenous aminophylline therapy. Group 1 consisted of 36 chronic obstructive pulmonary disease patients who were cigarette smokers without other conditions known to alter theophylline kinetics (age range: 22 to 79 years). Group 2 consisted of 23 chronic obstructive pulmonary disease patients who were cigarette smokers with a similar degree of congestive heart failure, but free of other characteristics or diseases that affect theophylline disposition (age range: 41 to 81 years). When individual theophylline total body clearance values were plotted against age in each group, poor correlation coefficients were found, indicating that age is not a good predictor of total body clearance of theophylline (group 1: r = 0.101; group 2: r = 0.276). Each group was also broken into ‘younger’ and ‘older’ patients. No significant differences in theophylline total body clearance values were found between the younger and older patients for either group 1 or 2, suggesting that a theophylline dosage reduction is not necessary in cigarette smoking patients over an arbitrary age limit.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blouin, R.A.; Elgert, J.F. and Bauer, L.A.: Theophylline clearance: Effect of severe obesity. Clinical Pharmacology and Therapeutics 28: 619–623 (1980).
Cusack, B.; Kelly, J.G.; Lavan, J.; Noel, J. and O’Malley, K.: Theophylline kinetics in relation to age: The importance of smoking. British Journal of Clinical Pharmacology 10: 109–114 (1980).
Devine, B.J.: Gentamicin therapy. Drug Intelligence and Clinical Pharmacy 8: 650–655 (1974).
Ellis, E.F.; Koysooko, R. and Levy, G.: Pharmacokinetics of theophylline in children with asthma. Pediatrics 58: 542–547 (1976).
Gal, P.; Jusko, W.J.; Yurchak, A.M. and Franklin, B.A.: Theophylline disposition in obesity. Clinical Pharmacology and Therapeutics 23: 438–444 (1978).
Hendeles, L.; Weinberger, M. and Bighley, L.: Disposition of theophylline after a single IV infusion of aminophylline. American Review of Respiratory Disease 118: 97–103 (1978).
Hunt, S.N.; Jusko, W.J. and Yurchak, A.M.: Effect of smoking on theophylline disposition. Clinical Pharmacology and Therapeutics 19: 546–551 (1976).
Jenne, J.; Nagasawa, H.; McHugh, R.; MacDonald, F. and Wyse, E.: Decreased theophylline half-life in cigarette smokers. Life Science 17: 195–198 (1975).
Jusko, W.J.; Koup, J.R.; Vance, J.W.; Schentag, J.J. and Kuritzky, P.: Intravenous theophylline therapy: Nomogram guidelines. Annals of Internal Medicine 86: 400–404 (1977).
Jusko, W.J.; Schentag, J.J.; Clark, J.H.; Gardner, M. and Yurchak, A.M.: Enhanced biotransformation of theophylline in marihuana and tobacco smokers. Clinical Pharmacology and Therapeutics 24: 406–410 (1978).
Jusko, W.J.; Gardner, M.J.; Mangione, A.; Schentag, J.J.; Koup, J.R. and Vance, J.W.: Factors affecting theophylline clearances. Journal of Pharmaceutical Sciences 68: 1358–1366 (1979).
Nielsen-Kudsk, F.; Magnussen, I. and Jakobsen, P.: Pharmacokinetics of theophylline in ten elderly patients. Acta Pharmacologica et Toxicologica 42: 234–266 (1978).
Peck, C.C.; Sheiner, L.B.; Martin, C.M.; Combs, D.T. and Melmon, K.L.: Computer-assisted digoxin therapy. New England Journal of Medicine 289: 441–446 (1973).
Piafsky, K.M.; Sitar, D.S.; Rango, R.E. and Ogilvie, R.I.: Theophylline kinetics in acute pulmonary edema. Clinical Pharmacology and Therapeutics 22: 310–316 (1977a).
Piafsky, K.M.; Sitar, D.S.; Rango, R.E. and Ogilvie, R.I.: Theophylline disposition in patients with hepatic cirrhosis. New England Journal of Medicine 296: 1495–1497 (1977b).
Powell, J.R.; Vozeh, S.; Hopewell, P.; Costello, J.; Sheiner, L.B. and Riegelman, S.: Theophylline disposition in acutely ill hospitalized patients: The effect of smoking, heart failure, severe airway obstruction and pneumonia. American Review of Respiratory Diseases 118: 229–238 (1978).
Vestal, R.E.; Wood, A.J.J.; Branch, R.A.; Shand, D.G. and Wilkinson, G.R.: Effects of age and cigarette smoking on propranolol disposition. Clinical Pharmacology and Therapeutics 26: 8–15 (1979).
Wood, A.J.J.; Vestal, R.E.; Wilkinson, G.R.; Branch, R.A. and Shand, D.G.: Effect of aging and cigarette smoking on anti-pyrine and indocyanine green elimination. Clinical Pharmacology and Therapeutics 26: 16–20 (1979).
Zaske, D.E.; Miller, K.W.; Strem, E.L.; Austrian, S. and Johnson, P.B.: Oral aminophylline therapy — increased dosage requirements in children. Journal of the American Medical Association 237: 1453–1455 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bauer, L.A., Blouin, R.A. Influence of Age on Theophylline Clearance in Patients with Chronic Obstructive Pulmonary Disease. Clin Pharmacokinet 6, 469–474 (1981). https://doi.org/10.2165/00003088-198106060-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198106060-00005